Coronavirus drugs: Who's doing what, and when they might come
Pharmaceuticals and research labs across the world are racing to find vaccines and treatments for the new coronavirus, using a variety of different technologies.
Mar 16, 2020
1
433
Pharmaceuticals and research labs across the world are racing to find vaccines and treatments for the new coronavirus, using a variety of different technologies.
Mar 16, 2020
1
433
U.S. researchers gave the first shot to the first person in a test of an experimental coronavirus vaccine Monday—leading off a worldwide hunt for protection even as the pandemic surges.
Mar 16, 2020
0
3713
Researchers at Karolinska Institutet are on track to produce a vaccine against the new coronavirus, SARS-CoV-2. Several vaccine candidates are currently available in the freezers at the Department of Laboratory Medicine and ...
Mar 9, 2020
0
4
Scientists from the Walter Reed Army Institute of Research have demonstrated that a novel, second-generation malaria vaccine candidate based on the tobacco mosaic virus may offer protection against Plasmodium falciparum malaria ...
Jan 28, 2020
0
138
University of Gothenburg researchers have reported the first successful results of an oral, inactivated vaccine candidate ETVAX against enterotoxigenic E. coli diarrhea in a placebo-controlled phase I/II study in infants ...
Nov 20, 2019
0
3
A report in the journal mBio, published by the American Society for Microbiology, describes a prototype vaccine candidate for Neisseria gonorrhoeae, the bacterium that causes gonorrhea, a sexually transmitted infection that ...
Nov 6, 2019
0
0
Immune responses that are associated with a decreased risk of infection are called correlates of protection (CoP). Clinical trials that measure vaccine-induced antibody and cell-mediated immune responses help to define CoP ...
Nov 1, 2019
0
2
A new type of vaccine that can be stored at warmer temperatures, removing the need for refrigeration, has been developed for mosquito-borne virus Chikungunya in a major advance in vaccine technology. The findings, published ...
Sep 25, 2019
0
144
A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock caused by invasive streptococcal disease, which kills more than 160,000 people every year.
Sep 4, 2019
0
154
In a new study, scientists led by the U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research identified a transcriptional signature in B cells associated with protection from SIV or HIV infection ...
Aug 28, 2019
0
84